Clorox's upgrade and new dividend level: Which is better?


The Clorox Company (NYSE: CLX), a company whose compatriots at the supermarket include Procter & Gamble (NYSE: PG) and Colgate-Palmolive (NYSE: CL), gave and received some good news this week. First, let's mention the giving. Management saw fit to increase the dividend that it pays to shareholders. The quarterly payout went up 9% to $0.50 per share.

Now, for the receiving. According to an earlier item on BloggingStocks, Oppenheimer thinks the stock is worthy of an outperform rating. A price target of $70 has been set. Which is impressive, since the price of Clorox as of this writing is $56.32 per share.


Without a doubt, the dividend raise should get more attention than the upgrade. No, I'm not coming down on Oppenheimer. I always enjoy it when payouts go up because not only does it show future confidence in cash flows, but it represents real return of value. And I have no doubt that Clorox will be able to back its dividend via its impressive stable of brands. Hey, who doesn't know and/or use the iconic bleach product?

Clorox, however, is a stock that should be looked at as a potential core holding. Sure, I see the merit of the upgrade. I see where Oppenheimer is coming from. But I wouldn't want to buy Clorox just on the upgrade. In fact, upgrades at this point in time should be vetted very carefully and thoroughly. Why? Because many stocks, like Clorox, have already made significant moves this year. Buying now could turn into a sour timing issue.

At an annual payment of $2 per year, that gives Clorox a current yield of roughly 3.5%. That's not bad. Locking in a decent yield now, holding shares and reinvesting dividends, and dollar-cost-averaging over a long period of time is a recipe for success with a company like Clorox.

With the economy possibly getting better, Clorox should hold its own against the private label industry. It won't be easy, though. Never underestimate the issue of generic store products. Don't become lulled into thinking that Clorox won't see pressure from such competition. Clorox will, however, remain a viable investment idea for the buy-to-keep crowd.

Disclosure: I don't own any company mentioned; positions can change without notice.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA-134.6012,755.86
NASDAQ-20.132,907.10
S&P 500-10.541,341.41

Last updated: February 10, 2012: 01:47 PM

Hot Stocks

General Electric

18.86-0.27(-1.41)

Alcoa

10.285-0.355(-3.34)

Apple Inc

493.26+0.09(+0.02)

Google Inc 'A'

605.11-6.35(-1.04)

Bank of America

8.085-0.095(-1.16)

Wal-Mart Stores

61.48-0.48(-0.77)

Exxon Mobil Corp

83.62-1.26(-1.48)

Ford

12.40-0.29(-2.29)

Citigroup

32.87-0.79(-2.35)

IBM

191.68-1.45(-0.75)

Yahoo

16.19+0.19(+1.19)

Starbucks

48.67-0.53(-1.08)

Microsoft

30.50-0.27(-0.88)

Home Depot

45.11-0.16(-0.35)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1328899658814 ms.